Literature DB >> 6303905

Construction of expression plasmids producing high levels of human leukocyte-type interferon in Escherichia coli.

E Dworkin-Rastl, P Swetly, M B Dworkin.   

Abstract

An expression plasmid was constructed, consisting of the promoter/operator region of the tryptophan operon from Serratia marcescens and a synthetic ribosome-binding site ligated into pBR322. Leukocyte-type interferon gene fragments (IFN-alpha A and IFN-alpha C) isolated from a cDNA library from human lymphoblastoid (Namalwa) cells were inserted into the unique HindIII site of the expression plasmid, and the resulting recombinant plasmids directed the synthesis of up to 5 X 10(5) units of A-type preinterferon, 2 X 10(7) units of A-type mature interferon and 8 X 10(5) units of C-type mature interferon per liter culture.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6303905     DOI: 10.1016/0378-1119(83)90007-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-alpha 2.

Authors:  D Neumann-Haefelin; R Sundmacher; H Frey; W Merk
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

2.  Low incidence of antibody formation due to long-term interferon-alpha 2c treatment of cancer patients.

Authors:  G G Steinmann; B Göd; F Rosenkaimer; G Adolf; G Bidlingmaier; B Frühbeis; H Lamche; J Lindner; E Patzelt; C Schmähling
Journal:  Clin Investig       Date:  1992-02

3.  A novel class of human type I interferons.

Authors:  R Hauptmann; P Swetly
Journal:  Nucleic Acids Res       Date:  1985-07-11       Impact factor: 16.971

4.  Periplasmic expression of human interferon-alpha 2c in Escherichia coli results in a correctly folded molecule.

Authors:  T Voss; E Falkner; H Ahorn; E Krystek; I Maurer-Fogy; G Bodo; R Hauptmann
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.